Britain | EUROPESAYS.COM
  • /
  • Europe
  • France
  • Spain
  • Canada
  • Australia
  • Africa
  • Football
  • Tennis
  • Golf
  • PM
  • England
    • London
    • Cambridgeshire
    • Cumbria
    • Derbyshire
    • Devon
    • Dorset
    • East Sussex
    • Essex
    • Gloucestershire
    • Hampshire
    • Hertfordshire
  • Britain
  • …
    • Germany
    • Italy
    • Ukraine
    • Poland
    • Netherlands
    • Russia
    • Iran
    • Japan
    • AI
  • @
  • AstraZeneca
  • BAE Systems
  • Barclays
  • BP
  • Britain
  • British American Tobacco
  • Compass Group
  • Diageo
  • Glencore
  • GSK
  • HSBC
  • Lloyds Banking Group
  • London
  • London Stock Exchange Group
  • National Grid
  • NatWest
  • Reckitt Benckiser
  • Rio Tinto
  • Rolls-Royce
  • Shell
  • Standard Chartered
  • UK
  • Unilever
Britain | EUROPESAYS.COM
  • /
  • Europe
  • France
  • Spain
  • Canada
  • Australia
  • Africa
  • Football
  • Tennis
  • Golf
  • PM
  • England
    • London
    • Cambridgeshire
    • Cumbria
    • Derbyshire
    • Devon
    • Dorset
    • East Sussex
    • Essex
    • Gloucestershire
    • Hampshire
    • Hertfordshire
  • Britain
  • …
    • Germany
    • Italy
    • Ukraine
    • Poland
    • Netherlands
    • Russia
    • Iran
    • Japan
    • AI
  • @

Browsing Tag

disease recurrence

3 posts
AAstraZeneca
FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy
Read More

FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy

  • June 1, 2026
AstraZeneca has received approval from the US Food and Drug Administration (FDA) for Imfinzi (durvalumab) in combination with…
AAstraZeneca
FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy
Read More

FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy

  • June 1, 2026
AstraZeneca has received approval from the US Food and Drug Administration (FDA) for Imfinzi (durvalumab) in combination with…
AAstraZeneca
UK Shares Rally at Start of New Week; Rio Tinto Shines
Read More

AstraZeneca’s Imfinzi Gets US FDA Nod for Bladder Cancer Combo Therapy

  • May 29, 2026
MT Newswires -Shutterstock The US Food and Drug Administration approved AstraZeneca’s (AZN.L, AZN,ST) Imfinzi, or durvalumab, in combination…
Britain | EUROPESAYS.COM
www.europesays.com